J&J booster 85% effective against Omicron hospitalization, says South Africa

14/01/2022 1:56:00 PM

JOHANNESBURG — A Johnson and Johnson COVID-19 vaccine booster shot is 85% effective in protecting against being hospitalized by the Omicron variant for 1-2 months after it is received, the head

A Johnson and Johnson COVID-19 vaccine booster shot is 85% effective in protecting against being hospitalized by the Omicron variant for 1-2 months after it is received, the head of SAMRC said.

JOHANNESBURG — A Johnson and Johnson COVID-19 vaccine booster shot is 85% effective in protecting against being hospitalized by the Omicron variant for 1-2 months after it is received, the head

Ps5 Digital vs Disc – Which One is Worth the Money? It looked at hospitalizations among those healthcare workers who had been infected during the fourth wave, and found that the booster shot reduced hospitalizations by 63% in the first two weeks after the booster, going up to 85% after that for between one and two months.AstraZeneca said on Thursday, January 13, preliminary data from a trial it conducted on its COVID-19 shot, Vaxzevria, showed it generated a higher antibody response against the Omicron variant and others, including Beta, Delta, Alpha and Gamma, when given as a third booster dose.Published January 12, 2022 11:23pm The study was conducted at the Emory Vaccine Center in Atlanta based on blood serum collected from 13 individuals, 28 days after their booster shot.WASHINGTON, United States — A preliminary US study of nearly 70,000 Covid positive people showed a substantially reduced risk of hospitalization and death from Omicron even after controlling for growing population immunity levels.

“This is the world’s first evidence of vaccine effectiveness (against Omicron) using the J&J vaccine,” Gray said.The South African authorities have thus far maintained a preference for the Pfizer vaccine — they have administered 21 million doses, three times as many as the roughly 7 million J&J vaccine doses.AstraZeneca has developed the vaccine with researchers from the University of Oxford, and lab studies last month found a three-dose course of Vaxzevria was effective against the rapidly spreading new variant.But the J&J shot is considered logistically much more preferable because it is a single-dose regimen, which is easier to administer in remote rural areas, where follow-ups can be difficult.The study was conducted at the Emory Vaccine Center in Atlanta based on blood serum collected from 13 individuals, 28 days after their booster shot.The data supported already strong global evidence that Omicron can evade vaccine protection when it comes to the initial infection.The company said it adds to the growing evidence that supports a third dose of its vaccine irrespective of the primary vaccination schedule.Among the participants in the study, there were about 30,000 breakthrough infections during the Omicron wave, compared with only around 11,000 each in the previous waves driven by the Delta and Beta variants.The analysis was conducted on data from the Kaiser Permanente Southern California hospital system, which serves a population of around 4.

The study also highlighted that those infected with HIV were more vulnerable to being hospitalized with Omicron.A major British trial in December found that AstraZeneca’s shot increased antibodies when given as a booster after initial vaccination with its own shot or Pfizer’s, which is based on mRNA technology."More than 90% of all individuals boosted with Covaxin showed neutralizing antibodies.ADVERTISEMENT “They (those being hospitalized) are more likely to have HIV and less likely to have other comorbidities as compared to the Beta and Delta period,” Gray said.HIV prevalence in South Africa is about 13%.– Rappler.The latest tech news delivered to your inbox By providing an email address.-- Reuters.I agree to the.The results thus suggest that Omicron is “intrinsically less severe than Delta,” and observed reductions in severe cases aren’t only the result of more people being vaccinated and infected over time, the paper said.

Read more:
Inquirer »
Loading news...
Failed to load news.

Sa pagkakaalam ko ang 'effective' na bakuna ay pang isang dekada kung di panghabambuhay 😂 Nung una pfizer at moderna mainam; sunod AztraZenica; ngayon J&J naman. Hintay lang ng konti at kumpleto nanaman listahan ng bakuna. Experto silang lahat! Paksyet after 1 to 2 months. Excellent! The never ending Vaccine. Will see what happens after several months or years. Remember everything is still under clinical trial. Just do whatever that makes you healthy. It's your body. 😷😷😷😷😷 FactsNotFear

Mali ata napili booster vaccine 💉 me. Nagkalagnat me after 2 days. pfizer So does vitamin C and biogesic. Get out vaccine!

New data finds AstraZeneca booster generates higher antibodies against OmicronThe company says the new data adds to the growing evidence that supports a third dose of its vaccine irrespective of the primary vaccination schedule.

India's Bharat Biotech says Covaxin booster shot neutralizes OmicronIndia&39;s Bharat Biotech said on Wednesday a booster shot of its Covaxin COVID-19 vaccine administered six months after the last of two doses neutralizes both the Omicron and Delta variants of the coronavirus.

Reduced hospitalization risk, shorter stays for Omicron patients: US studyPeople infected with Omicron were half as likely to be hospitalized, about 75 percent less likely to need intensive care, and around 90 percent less likely to die compared to those infected with the formerly dominant Delta variant, according to the paper. 😂 wait 2 weeks when the bacterial infection sets in

From delta to omicron, here’s how scientists know which coronavirus variants are circulating in the US | Alexander Sundermann, University of Pittsburgh Health Sciences and Lee Harrison, University of Pittsburgh Health SciencesHow do scientists know what versions of the coronavirus are present? How quickly can they see which viral variants are making inroads in a population? Epidemiologists who study novel approaches for outbreak detection explain how the genomic surveillance system works in the US and why it’s important to know which virus variants are…

Omicron especially dangerous for unvaccinated—WHOBut the UN health agency insisted there should be no surrender to the variant, dismissing the notion that it could be a welcome conduit to ending the pandemic. | via philstarlife

Omicron especially dangerous for unvaccinated—WHOThe Omicron variant of Covid-19 is dangerous -- and especially so for those who have not been vaccinated against the disease, the World Health Organization warned Wednesday. Good payer naman ako huhu! Stress is real Beware of that Snake in WHO it's real. Many doctors already says and study that omicron is less severe. Fear porn is real. FactsNotFear 😷😷😷